Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1990-5-31
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0002-922X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
144
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
526
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2330918-Administration, Oral,
pubmed-meshheading:2330918-Costs and Cost Analysis,
pubmed-meshheading:2330918-Enterocolitis, Pseudomembranous,
pubmed-meshheading:2330918-Humans,
pubmed-meshheading:2330918-Injections, Intravenous,
pubmed-meshheading:2330918-Metronidazole,
pubmed-meshheading:2330918-Vancomycin
|
pubmed:year |
1990
|
pubmed:articleTitle |
Antibiotic-associated pseudomembranous colitis.
|
pubmed:publicationType |
Letter
|